34 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
led successful mergers, acquisitions, and commercialization deals. These skills all will be helpful as we conduct our strategic review and continue
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
28 Apr 23
Additional proxy soliciting materials
4:03pm
and enhance shareholder value. Our Board and management team have the right skills and expertise to continue to unlock value for all shareholders. Each
DEF 14A
h5jdmq1ctuiz3 c85z0
10 May 21
Definitive proxy
4:06pm
PRE 14A
kw3kq31sr9hajugwzgw
27 Apr 21
Preliminary proxy
4:32pm
10-K
7ksa yzxw
24 Feb 21
Annual report
4:09pm
10-K
EX-10.16
4va rcxq9wx
24 Feb 21
Annual report
4:09pm
10-K
EX-10.17
94i102m4f2woc
24 Feb 21
Annual report
4:09pm
SUPPL
44lvs
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
d9cvgyftive
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
yzv2zb
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
u0cpncbukl6 9cjlznxp
29 May 20
Registration of securities (Canada)
4:07pm
6-K
EX-99.3
dv3f gk0bb9
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
40-F
EX-99.1
4pl19s0g
5 Mar 20
Annual report (Canada)
4:06pm